Careviso (Formerly CMT Solutions)
A technology healthcare company helping to simplify and streamline patient access for molecular diagnostics.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 6.5x EV/Revenue | round | |
| investor | €0.0 | round | |
* | $17.0m | Series B | |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 189 % | 16 % | 57 % | 15 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Careviso is a healthcare technology company that offers a platform to increase patient access to care by providing real-time cost estimates, administrative requirements, and approvals.
The company primarily serves physician offices that order diagnostic testing for their patients, with a particular focus on molecular diagnostics. Its platform, seeQer, allows healthcare administrators to quickly and accurately verify patient eligibility and benefits, estimate costs, and process prior authorizations.
Careviso's business model is centered on providing software solutions that simplify and streamline the often complex and time-consuming administrative processes associated with healthcare services. By automating these tasks, the company helps to reduce administrative burdens for healthcare providers and improve the patient experience.
Keywords: healthcare technology, patient access, molecular diagnostics, cost estimates, prior authorization, administrative simplification, revenue cycle management, patient transparency, seeQer, healthcare administration.